Daiwei Medical: Net profit is expected to increase by 52.02% year-on-year in 2025, with a proposed dividend of 0.8 yuan per share.

Daiwei Medical disclosed its annual report on April 2, reporting a operating revenue of 584 million yuan in 2025, a year-on-year increase of 10.82%; a net profit attributable to shareholders of 87.0533 million yuan, a year-on-year increase of 52.02%; and a basic earnings per share of 0.3 yuan. The company plans to distribute a cash dividend of 0.8 yuan for every 10 shares. During the reporting period, the company's research and development investment totaled 59.3049 million yuan, accounting for 10.15% of the operating revenue.